Patient Access & Affordability
Covers the affordability resources a rep must know when a provider raises a patient who can't afford a medication — including why manufacturer copay cards are off-limits for government-insured patients.
- 10 questions
- 15 min
- 70% to pass
Instant score · Full answer review · Study guide
What's covered
A full syllabus, not a mystery quiz.
What's covered
6 topics
01Why Copay Cards Don't Work for Government-Insured Patients
The federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b) prohibits manufacturers from offering anything of value — including copay cards — to induce a Medicare, Medicaid, TRICARE, or VA beneficiary to use a particular drug. Manufacturer copay cards are generally only usable by commercially (privately) insured patients.
02Manufacturer Patient Assistance Programs (PAPs)
PAPs are manufacturer-run programs that provide medication free or at deeply reduced cost directly to eligible patients — typically uninsured or underinsured — based on criteria like income and insurance status. This is separate from a copay card and is a compliant option for government-insured patients who qualify.
03Independent Charitable Foundations
Per HHS-OIG guidance, an independent charitable foundation can appropriately help government-insured patients only if it is truly independent of any single manufacturer, supports a disease state broadly rather than one specific product, and makes assistance decisions without manufacturer influence over individual patients.
04Medicare Extra Help / Low-Income Subsidy (LIS)
Extra Help is a federal program (also called the Part D Low-Income Subsidy) administered largely through Social Security that helps eligible low-income Medicare beneficiaries pay their Part D premiums, deductibles, and copays.
05The Part D Annual Out-of-Pocket Cap
Created by the Inflation Reduction Act of 2022, Medicare Part D now has a hard annual cap on a beneficiary's out-of-pocket drug costs — $2,000 in 2025, rising to $2,100 in 2026. Once a patient hits the cap, they pay $0 for covered Part D drugs for the rest of the calendar year.
06Medicare Prescription Payment Plan (Smoothing)
Also created by the IRA, this voluntary program lets a Medicare beneficiary spread their Part D out-of-pocket costs into monthly payments across the plan year instead of paying it all at the pharmacy when a prescription is filled. It improves cash flow but does not reduce the total amount owed.
More in Pharmaceutical Sales
Related knowledge tests

Pharma Compliance & Field Rules
Covers the field-facing compliance rules every rep operates under — sample handling, transparency reporting, promotional boundaries, HIPAA, and formulary pull-through.

US Healthcare System for Pharma Reps
Tests core knowledge of how Medicare, Medicaid, commercial insurance, and PBMs structure drug coverage and access — the payer landscape every field rep has to navigate.
Questions before you start
Know exactly what happens next.
No mystery quiz, surprise subscription, or vague pass/fail.
Is this test free?
Yes. Every new account gets one free graded test, no credit card required. After that, tests draw from your Mock Call credit balance.
What happens after I finish?
You get a graded breakdown immediately: your score, which questions you missed, and the correct answers, alongside the study guide above.
Can I retake it?
Yes. You can retake this test as many times as you have credits for and compare your score across attempts.
Do I need to study first?
Not necessarily — the study guide above covers all 6 topics on the test, so you can skim it first or just dive in.